L P Voruganti

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study
    L P Voruganti
    Department of Psychiatry and Behavioural Neurosciences, 100 West 5th Street, Hamilton, Ontario Canada L8N 3K7
    Schizophr Res 96:215-22. 2007
  2. doi New generation antipsychotic drugs and compliance behaviour
    Lakshmi P Voruganti
    McMaster University, Hamilton, Ontario, Canada
    Curr Opin Psychiatry 21:133-9. 2008
  3. ncbi Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine
    L P Voruganti
    McMaster University, Canada
    Schizophr Res 96:146-55. 2007
  4. ncbi Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study
    Lakshmi N P Voruganti
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, and Humber River Regional Hospital, Toronto, Ontario, Canada
    Schizophr Res 88:179-86. 2006
  5. ncbi Impact of atypical antipsychotics on quality of life in patients with schizophrenia
    A George Awad
    Institute of Medical Science and Department of Psychiatry, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, Canada
    CNS Drugs 18:877-93. 2004
  6. ncbi Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophrenia
    Lakshmi N P Voruganti
    St Joseph s Healthcare, Hamilton, Ontario
    Can J Psychiatry 51:575-80. 2006
  7. ncbi Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
    Lakshmi N P Voruganti
    Institute of Medical Science, University of Toronto, Toronto, Canada
    Schizophr Res 56:37-46. 2002
  8. ncbi The burden of schizophrenia on caregivers: a review
    A George Awad
    Department of Psychiatry and the Institute of Medical Science, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, M6M 3Z4, Canada
    Pharmacoeconomics 26:149-62. 2008
  9. ncbi New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?
    A George Awad
    University of Toronto, Institute of Medical Science, Ontario
    Can J Psychiatry 49:297-302. 2004
  10. ncbi Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale
    A George Awad
    Department of Psychiatry, Humber Regional Hospital, 1575 Keele Street, Toronto M6M 3Z4, Canada
    Schizophr Res 70:63-7. 2004

Collaborators

Detail Information

Publications11

  1. ncbi Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study
    L P Voruganti
    Department of Psychiatry and Behavioural Neurosciences, 100 West 5th Street, Hamilton, Ontario Canada L8N 3K7
    Schizophr Res 96:215-22. 2007
    ..Discerning the modifiable risk factors is crucial for developing diabetes prevention strategies in schizophrenia...
  2. doi New generation antipsychotic drugs and compliance behaviour
    Lakshmi P Voruganti
    McMaster University, Hamilton, Ontario, Canada
    Curr Opin Psychiatry 21:133-9. 2008
    ....
  3. ncbi Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine
    L P Voruganti
    McMaster University, Canada
    Schizophr Res 96:146-55. 2007
    ..Cognitive deficits are recognized as a critical determinant of functional outcomes in schizophrenia; and second generation antipsychotic drugs have been touted for their potential to enhance cognitive functioning and community tenure...
  4. ncbi Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study
    Lakshmi N P Voruganti
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, and Humber River Regional Hospital, Toronto, Ontario, Canada
    Schizophr Res 88:179-86. 2006
    ....
  5. ncbi Impact of atypical antipsychotics on quality of life in patients with schizophrenia
    A George Awad
    Institute of Medical Science and Department of Psychiatry, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, Canada
    CNS Drugs 18:877-93. 2004
    ....
  6. ncbi Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophrenia
    Lakshmi N P Voruganti
    St Joseph s Healthcare, Hamilton, Ontario
    Can J Psychiatry 51:575-80. 2006
    ..To undertake a preliminary study to assess the feasibility of clinical implementation and evaluate the effectiveness of a novel adventure- and recreation-based group intervention in the rehabilitation of individuals with schizophrenia...
  7. ncbi Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
    Lakshmi N P Voruganti
    Institute of Medical Science, University of Toronto, Toronto, Canada
    Schizophr Res 56:37-46. 2002
    ....
  8. ncbi The burden of schizophrenia on caregivers: a review
    A George Awad
    Department of Psychiatry and the Institute of Medical Science, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, M6M 3Z4, Canada
    Pharmacoeconomics 26:149-62. 2008
    ....
  9. ncbi New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?
    A George Awad
    University of Toronto, Institute of Medical Science, Ontario
    Can J Psychiatry 49:297-302. 2004
    ..This overview reviews the impact of second-generation antipsychotics on less frequently researched outcomes such as medication-adherence behaviour, quality of life, and subjective tolerability in patients with schizophrenia...
  10. ncbi Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale
    A George Awad
    Department of Psychiatry, Humber Regional Hospital, 1575 Keele Street, Toronto M6M 3Z4, Canada
    Schizophr Res 70:63-7. 2004
    ....
  11. pmc What's in a name? The evolution of the nomenclature of antipsychotic drugs
    Caroline King
    Department of Psychiatry, University of Western Ontario, London, Ont
    J Psychiatry Neurosci 27:168-75. 2002
    ..This article examines the origins, progenitors and usage of the word "antipsychotic" and explores its ramifications...